Quick Answer
BIO-TECHNE Corp reported Net Income Loss of $73.40 million for the year ending 2025.
- BIO-TECHNE Corp showed a decrease of -56.3% in Net Income Loss from 2024 to 2025.
- This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $22.71 million | Q4 2015: $25.85 million | Q1 2016: $30.29 million | Q2 2016: $25.63 million | Q3 2016: $18.84 million | Q4 2016: $7.47 million | Q1 2017: $22.17 million | Q2 2017: $27.61 million | Q3 2017: $15.86 million | Q4 2017: $48.85 million | Q1 2018: $19.74 million | Q2 2018: $41.70 million | Q3 2018: $17.40 million | Q4 2018: $17.56 million | Q1 2019: $44.65 million | Q2 2019: $16.46 million | Q3 2019: $14.40 million | Q4 2019: $119.62 million | Q1 2020: $36.43 million | Q2 2020: $58.85 million | Q3 2020: $33.40 million | Q4 2020: $46.27 million | Q1 2021: $45.78 million | Q3 2021: $69.62 million | Q4 2021: $80.17 million | Q1 2022: $60.74 million | Q3 2022: $89.56 million | Q4 2022: $50.01 million | Q1 2023: $70.22 million | Q3 2023: $50.99 million | Q4 2023: $27.47 million | Q1 2024: $49.06 million | Q3 2024: $33.60 million | Q4 2024: $34.89 million | Q1 2025: $22.59 million | Q3 2025: $38.19 million | Q4 2025: $38.01 million.
- Over the full 17 years of available data (2009 to 2025), BIO-TECHNE Corp's Net Income Loss has declined by 30.3%.
- Historical annual values: Fiscal year 2025: $73.40 million | Fiscal year 2024: $168.11 million | Fiscal year 2023: $285.26 million | Fiscal year 2022: $272.05 million | Fiscal year 2021: $140.41 million | Fiscal year 2020: $229.30 million | Fiscal year 2019: $96.07 million | Fiscal year 2018: $126.15 million | Fiscal year 2017: $76.09 million | Fiscal year 2016: $104.48 million | Fiscal year 2015: $107.74 million | Fiscal year 2014: $110.95 million | Fiscal year 2013: $112.56 million | Fiscal year 2012: $112.33 million | Fiscal year 2011: $112.30 million | Fiscal year 2010: $109.78 million | Fiscal year 2009: $105.24 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: